RANDOMIZED, MULTICENTER STUDY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: RESULTS AT 12 MONTHS

被引：0
|
作者：
Saliba, Faouzi [1 ]
Duvoux, Christophe [2 ]
Durand, Francois [3 ]
Neau-Cransac, Martine [4 ]
Hardwigsen, Jean [5 ]
Pageaux, Georges [6 ]
Boleslawski, Emmanuel [7 ]
机构：
[1] Hop Paul Brousse, AP HP, Ctr Hepatobiliaire, Villejuif, France
[2] Hop Henri Mondor, AP HP, Creteil, France
[3] Hop Beaujon, AP HP, Clichy, France
[4] Hop Pellegrin, F-33076 Bordeaux, France
[5] Hop Conception, Marseille, France
[6] Hop St Eloi, Montpellier, France
[7] Hop Claude Huriez, Lille, France
来源：
TRANSPLANT INTERNATIONAL | 2012年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：39 / 39
页数：1
相关论文
共 50 条
  • [41] Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study
    Fischer, Lutz
    Saliba, Faouzi
    Kaiser, Gernot M.
    De Carlis, Luciano
    Metselaar, Herold J.
    De Simone, Paolo
    Duvoux, Christophe
    Nevens, Frederik
    Fung, John J.
    Dong, Gaohong
    Rauer, Barbara
    Junge, Guido
    [J]. TRANSPLANTATION, 2015, 99 (07) : 1455 - 1462
  • [42] Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation
    Chapman, William C.
    Brown, Robert S.
    Chavin, Kenneth D.
    Sudan, Debra
    Koneru, Baburao
    Junge, Guido
    Dong, Gaohong
    Patel, Dharmesh
    Teperman, Lewis
    Fung, John J.
    [J]. TRANSPLANTATION, 2017, 101 (02) : 341 - 349
  • [43] PHARMACOKINETICS OF EVEROLIMUS WHEN COMBINED WITH TACROLIMUS IN DE NOVO RENAL TRANSPLANT RECIPIENTS
    Rostaing, L.
    Pascual, J.
    Machein, U.
    Kovarik, J. M.
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 253 - 253
  • [44] EARLY WITHDRAWAL OF CALCINEURIN INHIBITORS AND EVEROLIMUS MONOTHERAPY IN DE NOVO LIVER TRANSPLANT RECIPIENTS
    Montalti, Roberto
    Rompianesi, Gianluca
    Masetti, Michele
    Di Benedetto, Fabrizio
    Cautero, Nicola
    De Ruvo, Nicola
    Guerrini, Gian Piero
    Ballarin, Roberto
    Smerieri, Nazareno
    Gerunda, Giorgio E.
    [J]. LIVER TRANSPLANTATION, 2009, 15 (07) : S96 - S97
  • [45] The H2304E1 Study: Efficacy and Safety of Everolimus With Reduced Tacrolimus Versus Standard Tacrolimus in De Novo Liver Transplant Recipients at 36 Months.
    De Simone, P.
    Kaiser, G. M.
    De Carlis, L.
    Metselaar, H. J.
    Duvoux, C.
    Nevens, F.
    Fischer, L.
    Fung, J.
    Dong, G.
    Rauer, B.
    Junge, G.
    Saliba, F.
    [J]. LIVER TRANSPLANTATION, 2014, 20 : S106 - S106
  • [46] Hephaistos Study Outcome on Renal Function after 12 Month Everolimus Plus Reduced Tacrolimus in De Novo Liver Transplant Recipients versus Standard Tacrolimus.
    Braun, F.
    Schemmer, P.
    Schlitt, H.
    Pascher, A.
    Klein, C.
    Neumann, U.
    Kroeger, I.
    Wimmer, P.
    Nashan, B.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 556 - 556
  • [47] Lower Incidence of Viral Infections with Everolimus Versus MMF in De Novo Heart Transplant Recipients: 12 Month Analysis of a Randomized Multicenter Study
    Ross, H.
    Kfoury, A. G.
    Van Bakel, A.
    Ewald, G.
    Burton, J.
    Andreassen, A.
    Segovia, J.
    Lopez, P.
    Cines, M.
    Dong, G.
    Potena, L.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S63 - S64
  • [48] Renal Dysfunction at 12 Months Is Not Associated with Everolimus Exposure in De Novo Renal Transplant Recipients.
    Shihab, F.
    Qazi, Y.
    Mulgaonkar, S.
    McCague, K.
    Patel, D.
    Peddi, V.
    Shaffer, D.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 544 - 544
  • [49] 12 MONTHS OUTCOMES ON ALLOGRAFT FUNCTION WITH EVEROLIMUS-CNI VS TACROLIMUS-MPA REGIMEN IN DE NOVO RENAL TRANSPLANT RECIPIENTS: THE ATHENA STUDY
    Merville, P.
    Kamar, N.
    Dragun, D.
    Sommerer, C.
    Suwelack, B.
    Schenker, P.
    Hauser, I. A.
    Witzke, O.
    Hugo, C.
    Junge, M.
    Thaiss, F.
    Nashan, B.
    [J]. TRANSPLANT INTERNATIONAL, 2018, 31 : 15 - 15
  • [50] HEPHAISTOS study: Early use of everolimus plus reduced tacrolimus in de novo liver transplant recipients achieves high efficacy and safety compared to standard tacrolimus.
    Schemmer, P.
    Nashan, B.
    Braun, F.
    Pascher, A.
    Klein, C. -G
    Neumann, U.
    Kroeger, I
    Wimmer, P.
    Schlitt, H. J.
    [J]. TRANSPLANTATION, 2019, 103 (08) : 298 - 298
12345